0 likes | 13 Views
Orphan medicines market globally The CDMO industry has risen dramatically due to a variety of factors, including greater awareness of rare diseases and attractive government incentives such as tax cuts, fee waivers, and extended marketing exclusivity for orphan drugs.
E N D